DELCATH SYSTEMS, INC.
Surgical & Medical Instruments & Apparatus · 566 QUEENSBURY AVENUE, QUEENSBURY, NY 12804
官方登記資料
0位追蹤者
1988成立於
關於 DELCATH SYSTEMS, INC.
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally.
Source: Wikipedia
產業Surgical & Medical Instruments & Apparatus
總部566 QUEENSBURY AVENUE, QUEENSBURY, NY 12804
成立時間1988
法律形式C Corporation
狀態營運中
專利26 項專利
APPARATUS FOR REMOVING CHEMOTHERAPY COMPOUNDS FROM BLOODEP2776086A4 · 2016
Filter and Frame Apparatus and Method of UseUS2016193401A1 · 2016
關鍵數據
法律資訊
| 法定名稱 | DELCATH SYSTEMS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 872912在 SEC EDGAR 上查看 ↗ |
| EIN | 06-1245881 |
| 產業代碼(SIC) | 3841 |
| 登記地址 | 566 QUEENSBURY AVENUE, QUEENSBURY, NY 12804 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
566 QUEENSBURY AVENUE, QUEENSBURY, NY 12804
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面